In last two decades, the country’s IP model continues to serve as a global benchmark for balancing innovation with public ...

Daiichi Sankyo signs a $300m deal with Alteogen to develop a subcutaneous version of anti-HER2 cancer drug Enhertu. ... (trastuzumab deruxtecan) makes it to market and meets sales targets. ...

Phesgo comes in a single-dose vial and can be dosed as a subcutaneous injection, while at the moment breast cancer patients the two anti-HER2 drugs separately receive Herceptin as a subcutaneous ...

An intramuscular injection is a technique used to deliver a medication deep into the muscles. This allows the medication to be absorbed quickly. Learn more.